ZyVersa Therapeutics and University of Miami Awarded a Grant from The Michael J. Fox Foundation to Determine if Inhibition of Microglial Inflammasome Activation with IC 100 Blocks Neuroinflammation Driving Parkinson’s Disease Pathology

Compelling evidence that chronic neuroinflammation induces neurodegeneration in Parkinson’s disease (PD) Hypothesized that microglial inflammasome activation propagates chronic neuroinflammation in PD IC 100, a CNS-penetrating monoclonal ASC Inhibitor, targets multiple types of…